Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells (vol 240, pg 426, 2015)

被引：0
|
作者：
Huang, O.
Zhang, W.
Zhi, Q.
Xue, X.
Liu, H.
Shen, D.
Geng, M.
Xie, Z.
Jiang, M.
机构：
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2020年 / 245卷 / 03期
关键词：
D O I：
10.1177/1535370220901429
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：NP2 / NP2
页数：1
相关论文
共 50 条
  • [1] Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells
    Huang, Ou
    Zhang, Weili
    Zhi, Qiaoming
    Xue, Xiaofeng
    Liu, Hongchun
    Shen, Daoming
    Geng, Meiyu
    Xie, Zuoquan
    Jiang, Min
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 240 (04) : 426 - 437
  • [2] Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple-negative breast cancer (TNBC) cells via modulation of multiple cell signal pathways
    Jiang, M.
    Huang, O.
    Xie, Z.
    Shen, K.
    CANCER RESEARCH, 2013, 73
  • [3] Synergistic anticancer activity of Sulphoraphane and Teriflunomide co loaded lignin nanoparticles against triple negative breast cancer: Targeted nanoparticle delivery and drug repurposing
    Dutta, Debopriya
    Siddiqui, Lubna
    Shah, Sadia
    Talegaonkar, Sushama
    MEDICAL HYPOTHESES, 2024, 189
  • [4] Molecular Mechanism by which Coumestrol Exerts its Anticancer Activity in Triple-Negative Inflammatory Breast Cancer
    Rodriguez-Martir, Keishla M.
    Colon-Ortiz, Ayeisha N.
    Fuxa-Rey, Veronica
    Negron-Figueroa, Dalissa
    Morales-Rivera, Carlos S.
    Carrasquillo-Dones, Emmanuel A.
    Peterson-Peguero, Esther A.
    FASEB JOURNAL, 2022, 36
  • [5] The Proteomic Landscape of Triple-Negative Breast Cancer (vol 11, pg 630, 2015)
    Lawrence, Robert T.
    Perez, Elizabeth M.
    Hernandez, Daniel
    Miller, Chris P.
    Haas, Kelsey M.
    Irie, Hanna Y.
    Lee, Su-In
    Blau, C. Anthony
    Villen, Judit
    CELL REPORTS, 2015, 11 (06): : 990 - 990
  • [6] Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells
    Semkova, Severina
    Nikolova, Biliana
    Tsoneva, Iana
    Antov, Georgi
    Ivanova, Donika
    Angelov, Anton
    Zhelev, Zhivko
    Bakalova, Rumiana
    ANTICANCER RESEARCH, 2023, 43 (03) : 1207 - 1212
  • [7] Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells
    Burnett, Joseph P.
    Lim, Gi
    Li, Yanyan
    Shah, Ronak B.
    Lim, Rebekah
    Paholak, Hayley J.
    McDermott, Sean P.
    Sun, Lichao
    Tsume, Yasuhiro
    Bai, Shuhua
    Wicha, Max S.
    Sun, Duxin
    Zhang, Tao
    CANCER LETTERS, 2017, 394 : 52 - 64
  • [8] Deciphering the molecular mechanism underlying anticancer activity of coumestrol in triple-negative breast cancer cells
    Zafar, Atif
    Singh, Swarnendra
    Satija, Yatendra Kumar
    Saluja, Daman
    Naseem, Imrana
    TOXICOLOGY IN VITRO, 2018, 46 : 19 - 28
  • [9] Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells
    Zheng, Meiling
    Mei, Zhiqiang
    Junaid, Md
    Tania, Mousumi
    Fu, Junjiang
    Chen, Han-Chun
    Khan, Md Asaduzzaman
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (06) : 1111 - 1118
  • [10] The role of taxanes in triple-negative breast cancer: literature review (vol 9, pg 4303, 2015)
    Mustacchi, G.
    De laurentiis, M.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5669 - 5669
12345